| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/24/2003 | WO2003106669A1 Purified pkb ser 473 kinase and uses thereof |
| 12/24/2003 | WO2003106644A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | WO2003106640A2 Cell targeting methods and compositions |
| 12/24/2003 | WO2003106639A2 Recombination of nucleic acid library members |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106500A1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 12/24/2003 | WO2003106499A1 Antibody and inhibitor and transformation method and transformation kit using the same |
| 12/24/2003 | WO2003106498A2 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus |
| 12/24/2003 | WO2003106483A1 A recombinant anti-enveloped virus peptide and its preparation |
| 12/24/2003 | WO2003106478A2 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 12/24/2003 | WO2003105989A1 Use of a clathrate modifier to promote passage of proteins during nanofiltration |
| 12/24/2003 | WO2003105899A1 Apparatus and methods for detecting cerebrospinal fluid |
| 12/24/2003 | WO2003105898A1 Modified "s" antibodies |
| 12/24/2003 | WO2003105894A1 Stabilized liquid anti-rsv antibody formulations |
| 12/24/2003 | WO2003105884A1 Use of shp-1 for the therapy of asthma |
| 12/24/2003 | WO2003105814A1 In vivo imaging of apoptosis |
| 12/24/2003 | WO2003105782A2 Specificity grafting of a murine antibody onto a human framework |
| 12/24/2003 | WO2003105757A2 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 12/24/2003 | WO2003091274A3 Use of alpha-s2 casein precursor-derived peptided |
| 12/24/2003 | WO2003083071A3 Diabetes-related immunoglobulin derived proteins, compositions, methods and uses |
| 12/24/2003 | WO2003075951A3 Novel application of vaccination against tnf-alpha |
| 12/24/2003 | WO2003072598A3 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 12/24/2003 | WO2003064473A3 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 12/24/2003 | WO2003022990A3 Production of fusion proteins and use for identifying binding molecules |
| 12/24/2003 | WO2003014353A3 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 12/24/2003 | WO2003005033A3 Carcinoma-related peptides |
| 12/24/2003 | WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002096455A3 Use of polyclonal immunoglobulins |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002081703A3 Mitogenic oxygenase regulators |
| 12/24/2003 | WO2002057435A3 Bifunctional fusion proteins with glucocerebrosidase activity |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002026805A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/24/2003 | CN1132014C Icam－4抗体的应用 Icam-4 antibody applications |
| 12/24/2003 | CA2723500A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | CA2722998A1 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 12/24/2003 | CA2495047A1 Methods and compositions for in vivo clearance of pathogens |
| 12/24/2003 | CA2489726A1 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | CA2489632A1 Stabilized liquid anti-rsv antibody formulations |
| 12/24/2003 | CA2489595A1 Recombination of nucleic acid library members |
| 12/24/2003 | CA2489534A1 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | CA2489474A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 12/24/2003 | CA2489469A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489316A1 Antibody and inhibitor, and transfection method or kit using them |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489280A1 Modified "s" antibodies |
| 12/24/2003 | CA2489214A1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 12/24/2003 | CA2489004A1 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | CA2488836A1 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 12/24/2003 | CA2487321A1 Specificity grafting of a murine antibody onto a human framework |
| 12/24/2003 | CA2479938A1 In vivo imaging of apoptosis |
| 12/23/2003 | US6667295 DNA vaccine against feline immunodeficiency virus |
| 12/23/2003 | US6667162 Isolating the Fkhsf polypeptide from cultured recombinant host cells. |
| 12/23/2003 | US6667158 Antibodies against type a botulinum neurotoxin |
| 12/23/2003 | US6667156 Treating nervous system tumors; obtain cells, incubate with modulator, evaluate tumor propagtion |
| 12/23/2003 | US6667039 Delivering therapeutic agent to CD30+ malignant cells by contacting with conjugate comprising one or more agents attached to soluble CD30 ligand polypeptide having specified amino acid sequence |
| 12/23/2003 | US6667036 Administering antibody to a protein component or to a carbohydrate-protein component of P-selectin glycoprotein ligand for therapy of rheumatoid arthritis |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents |
| 12/18/2003 | WO2003104820A2 Extraction and quantification of vitamins a and d in fluid samples |
| 12/18/2003 | WO2003104812A2 ASSAY FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE RATIO OF hAbeta42:hAbeta40 |
| 12/18/2003 | WO2003104806A1 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same |
| 12/18/2003 | WO2003104803A2 Method for mapping and eliminating t-cell epitopes |
| 12/18/2003 | WO2003104453A1 Method of constructing antibody |
| 12/18/2003 | WO2003104437A2 Anti-addl antibodies and uses thereof |
| 12/18/2003 | WO2003104434A2 A method to amplify variable sequences without imposing primer sequences |
| 12/18/2003 | WO2003104432A2 Anti-cd30 stalk and anti-cd30 antibodies suitable for use in immunotoxins |
| 12/18/2003 | WO2003104429A2 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 12/18/2003 | WO2003104428A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | WO2003104425A2 Novel stable anti-cd22 antibodies |
| 12/18/2003 | WO2003104421A2 Immunocapture and functional assay for mitochondrial f1/f0 atpase |
| 12/18/2003 | WO2003104418A2 Reconstituted polypeptides |
| 12/18/2003 | WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain |
| 12/18/2003 | WO2003104281A1 Antibodies to adipose tissues |
| 12/18/2003 | WO2003104280A1 Anti-pharyngolaryngitis composition with igy and its agent |
| 12/18/2003 | WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/18/2003 | WO2003103712A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 12/18/2003 | WO2003103711A1 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 12/18/2003 | WO2003103709A2 Modulation of bone development |
| 12/18/2003 | WO2003103662A2 Inhibitors of glycoprotein vi |
| 12/18/2003 | WO2003103532A2 Method for improving body weight gain and feed conversion efficiency in animals |
| 12/18/2003 | WO2003103481A2 Methods for detecting b. anthracis infection |
| 12/18/2003 | WO2003074558A3 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom |
| 12/18/2003 | WO2003074549A3 Assay for anti-ingap antibodies |
| 12/18/2003 | WO2003059953A3 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 12/18/2003 | WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 12/18/2003 | WO2003055979A3 ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS |
| 12/18/2003 | WO2003054020A3 Human antibodies against human glycoprotein vi and their use |
| 12/18/2003 | WO2003045309A3 Peptides, peptide compositions,and methods of use in binding p 185 |
| 12/18/2003 | WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 12/18/2003 | WO2003029437A3 Secreted proteins |